Basic Information
RNALocate ID: RLID-D:11000051
RNA Symbol: hsa-miR-181c-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-181c-5p
RNA ID: miRBase:MIMAT0000258
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: B lymphoblastoid cells|Endothelial cells
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001631 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001632 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001633 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11001419 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11001420 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001421 Exosome Ovarian follicular fluid 22116803
RLID:11001422 Exosome Brain tissue 23382797
RLID:11001423 Exosome Plasma 23663360
RLID:11001424 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11001425 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000320 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-181c-5p Multiple sclerosis chronic progressive MNDR-E-MI-19991
MNDR hsa-miR-181c-5p Medulloblastoma MNDR-E-MI-19992
MNDR hsa-miR-181c-5p Uterine corpus endometrial carcinoma MNDR-E-MI-19993
MNDR hsa-miR-181c-5p Lymphoma MNDR-E-MI-19994
MNDR hsa-miR-181c-5p Estrogen-receptor positive breast cancer MNDR-E-MI-19995
MNDR hsa-miR-181c-5p Progesterone-receptor positive breast cancer MNDR-E-MI-19996
MNDR hsa-miR-181c-5p Progesterone-receptor negative breast cancer MNDR-E-MI-19997
MNDR hsa-miR-181c-5p Breast cancer luminal MNDR-E-MI-19998
MNDR hsa-miR-181c-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-19999
MNDR hsa-miR-181c-5p B cell acute lymphoblastic leukemia MNDR-E-MI-20000
MNDR hsa-miR-181c-5p Dermatomyositis MNDR-E-MI-20001
MNDR hsa-miR-181c-5p Prostate cancer MNDR-E-MI-20002
MNDR hsa-miR-181c-5p Gastric cancer MNDR-E-MI-20003
MNDR hsa-miR-181c-5p Alzheimer disease MNDR-E-MI-20004
MNDR hsa-miR-181c-5p Dysautonomia familial MNDR-E-MI-20005
MNDR hsa-miR-181c-5p Seizures MNDR-E-MI-20006
MNDR hsa-miR-181c-5p Leukemia MNDR-E-MI-20007
MNDR hsa-miR-181c-5p Ataxia telangiectasia MNDR-E-MI-20008
MNDR hsa-miR-181c-5p Huntington disease MNDR-E-MI-20009
MNDR hsa-miR-181c-5p Cardiovascular disease MNDR-E-MI-20010
MNDR hsa-miR-181c-5p Lung cancer MNDR-E-MI-20011
MNDR hsa-miR-181c-5p Down syndrome MNDR-E-MI-20012
MNDR hsa-miR-181c-5p Parkinson disease MNDR-E-MI-20013
MNDR hsa-miR-181c-5p Breast cancer MNDR-E-MI-20014
MNDR hsa-miR-181c-5p Thyroid cancer MNDR-E-MI-20015
MNDR hsa-miR-181c-5p Pituitary neoplasms MNDR-E-MI-20016
MNDR hsa-miR-181c-5p Pancreatic cancer MNDR-E-MI-20017
MNDR hsa-miR-181c-5p Melanoma MNDR-E-MI-20018
MNDR hsa-miR-181c-5p Nephroblastoma MNDR-E-MI-20019
MNDR hsa-miR-181c-5p Colon cancer MNDR-E-MI-20020
MNDR hsa-miR-181c-5p Colon adenocarcinoma MNDR-E-MI-20021
MNDR hsa-miR-181c-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-20022
MNDR hsa-miR-181c-5p Ovarian cancer MNDR-E-MI-20023
MNDR hsa-miR-181c-5p Prostate adenocarcinoma MNDR-E-MI-20024
MNDR hsa-miR-181c-5p Carcinoma ductal breast MNDR-E-MI-20025
MNDR hsa-miR-181c-5p Glioblastoma MNDR-E-MI-20026
MNDR hsa-miR-181c-5p Glioma MNDR-E-MI-20027
MNDR hsa-miR-181c-5p Amyotrophic lateral sclerosis MNDR-E-MI-20028
MNDR hsa-miR-181c-5p Osteosarcoma MNDR-E-MI-20029
MNDR hsa-miR-181c-5p Inclusion body myositis MNDR-E-MI-20030
MNDR hsa-miR-181c-5p Gastric adenocarcinoma MNDR-E-MI-20031
MNDR hsa-miR-181c-5p Cervical squamous cell carcinoma MNDR-E-MI-20032
MNDR hsa-miR-181c-5p Bone-invasive pituitary adenoma MNDR-E-MI-20033
MNDR hsa-miR-181c-5p Lung squamous cell carcinoma MNDR-E-MI-20034
MNDR hsa-miR-181c-5p Lung adenocarcinoma MNDR-E-MI-20035
MNDR hsa-miR-181c-5p Thyroid carcinoma MNDR-E-MI-20036
MNDR hsa-miR-181c-5p Bladder urothelial carcinoma MNDR-E-MI-20037
MNDR hsa-miR-181c-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-20038
MNDR hsa-miR-181c-5p Carcinoma renal cell MNDR-E-MI-20039
MNDR hsa-miR-181c-5p Kidney renal papillary cell carcinoma MNDR-E-MI-20040
MNDR hsa-miR-181c-5p Clear cell renal cell carcinoma MNDR-E-MI-20041
MNDR hsa-miR-181c-5p Cholangiocarcinoma MNDR-E-MI-20042
MNDR hsa-miR-181c-5p Esophageal cancer MNDR-E-MI-20043
MNDR hsa-miR-181c-5p Synovial sarcoma MNDR-E-MI-20044
MNDR hsa-miR-181c-5p Stomach carcinoma MNDR-E-MI-20045
MNDR hsa-miR-181c-5p Head and neck squamous cell carcinoma MNDR-E-MI-20046
MNDR hsa-miR-181c-5p T acute lymphoblastic leukemia MNDR-E-MI-20047
MNDR hsa-miR-181c-5p Acute t cell leukemia MNDR-E-MI-20048
MNDR hsa-miR-181c-5p Breast invasive carcinoma MNDR-E-MI-20049
MNDR hsa-miR-181c-5p Hepatocellular carcinoma MNDR-E-MI-20050
MNDR hsa-miR-181c-5p Embryonal cancer MNDR-E-MI-20051
MNDR hsa-miR-181c-5p B-cell lymphoma MNDR-E-MI-20052
MNDR hsa-miR-181c-5p Rheumatoid arthritis MNDR-E-MI-20053
MNDR hsa-miR-181c-5p T-cell leukemia MNDR-E-MI-20054
MNDR hsa-miR-181c-5p Retinoblastoma MNDR-E-MI-20055
MNDR hsa-miR-181c-5p Hodgkin lymphoma MNDR-E-MI-20056
MNDR hsa-miR-181c-5p Burkitt lymphoma MNDR-E-MI-20057
MNDR hsa-miR-181c-5p Dementia vascular MNDR-E-MI-20058
MNDR hsa-miR-181c-5p Tonsil cancer MNDR-E-MI-20059
MNDR hsa-miR-181c-5p Neuromyelitis optica MNDR-E-MI-20060
MNDR hsa-miR-181c-5p Acute myelocytic leukemia MNDR-E-MI-20061
MNDR hsa-miR-181c-5p Colorectal cancer MNDR-E-MI-20062
MNDR hsa-miR-181c-5p Acute lymphocytic leukemia MNDR-E-MI-20063
MNDR hsa-miR-181c-5p Inflammatory breast neoplasms MNDR-E-MI-20064
MNDR hsa-miR-181c-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-20065
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter BCL2 Homo sapiens RR00219008
TOP